Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Welsprin Gold
Welsprin Gold is an advanced cardiovascular care formulation combining Atorvastatin, Clopidogrel, and Aspirin. This unique triple-combination therapy provides comprehensive heart protection by reducing cholesterol levels, preventing clot formation, and maintaining vascular health. It is recommended for patients at risk of cardiovascular diseases, stroke, or coronary artery disorders.
Uses of Welsprin Gold
Management of dyslipidemia and hypercholesterolemia
Prevention of atherosclerosis and cardiovascular diseases
Reduction of risk for myocardial infarction (heart attack) and stroke
Prevention of blood clot formation in high-risk patients
Benefits of Welsprin Gold
Triple-action formula: Combines cholesterol-lowering and antiplatelet therapy
Reduces LDL cholesterol and triglycerides while increasing HDL levels
Prevents clot formation, reducing the risk of heart attacks and strokes
Improves vascular health and reduces arterial inflammation
Convenient single-dose therapy for enhanced patient compliance
Mechanism of Action of Welsprin Gold
Atorvastatin: Inhibits HMG-CoA reductase, reducing cholesterol synthesis in the liver.
Clopidogrel: Blocks the P2Y12 receptor on platelets, preventing clot formation.
Aspirin: Irreversibly inhibits cyclooxygenase-1 (COX-1), reducing thromboxane A2 production and preventing platelet aggregation.